Net Loss of $1.08 per Diluted Common Share and Non-GAAP Operating Loss1 of $1.10 per Diluted Common Share; Return on Common Equity (“ROE”) of (9.5)% and Non-GAAP Operating ROE1 of (9.6)% Quarterly Analyst Conference Call Rescheduled for Friday, July 19, 2024, at 8:00 AM ET In the second…